Hospira revenue rises 14 percent on higher sales of injectable drugs

(Reuters) – Drugmaker Hospira Inc reported a 14.1 percent rise in quarterly revenue as it charged higher prices and sold more of its injectable drugs. The company’s net income rose to $158.6 million, or 92 cents per share, in the quarter ended Sept. 30 from $1.9 million, or 1 cent per share, a year earlier. The increase was mainly due to a $106.3 million gain on the sale of its clinical surveillance software business, Theradoc. Revenue rose to $1.2 billion from $1 billion. Sales of injectable drugs rose 16.7 percent and accounted for about 55 percent of total sales. …
Go to Source

Ebola surging in Sierra Leone amid lack of treatment centers: U.N.

Health workers spray themselves with chlorine disinfectants after removing the body a woman who died of Ebola virus in the Aberdeen district of FreetownDAKAR (Reuters) – The number of Ebola cases is surging in Sierra Leone as the country suffers from a lack of treatment centers, while lack of food and basic goods is forcing some people to leave quarantine areas, the United Nations said. The U.N. Mission for Ebola Emergency Response (UNMEER) said in its weekly report that a total of 1,062 people had died in Sierra Leone from the virus, with the outbreak particularly virulent in the western areas around the coastal capital Freetown. Sierra Leone is emerging as the focal point for concern in the worst Ebola outbreak on record. …

Go to Source

1 44 45 46 47 48 55